198 related articles for article (PubMed ID: 25818846)
1. Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease.
Takeda A; Tamano H
Expert Opin Ther Targets; 2015; 19(8):1051-8. PubMed ID: 25818846
[TBL] [Abstract][Full Text] [Related]
2. Is interaction of amyloid β-peptides with metals involved in cognitive activity?
Tamano H; Takeda A
Metallomics; 2015 Aug; 7(8):1205-12. PubMed ID: 25959547
[TBL] [Abstract][Full Text] [Related]
3. The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity.
Crouch PJ; Savva MS; Hung LW; Donnelly PS; Mot AI; Parker SJ; Greenough MA; Volitakis I; Adlard PA; Cherny RA; Masters CL; Bush AI; Barnham KJ; White AR
J Neurochem; 2011 Oct; 119(1):220-30. PubMed ID: 21797865
[TBL] [Abstract][Full Text] [Related]
4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
5. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
6. Insight into glutamate excitotoxicity from synaptic zinc homeostasis.
Takeda A
Int J Alzheimers Dis; 2010 Dec; 2011():491597. PubMed ID: 21234391
[TBL] [Abstract][Full Text] [Related]
7. Significance of synaptic Zn
Tamano H; Koike Y; Nakada H; Shakushi Y; Takeda A
J Trace Elem Med Biol; 2016 Dec; 38():93-98. PubMed ID: 26995290
[TBL] [Abstract][Full Text] [Related]
8. Amyloid β attenuates metabotropic zinc sensing receptor, mZnR/GPR39, dependent Ca
Abramovitch-Dahan C; Asraf H; Bogdanovic M; Sekler I; Bush AI; Hershfinkel M
J Neurochem; 2016 Oct; 139(2):221-233. PubMed ID: 27501363
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Zn(2+) signaling in cognition.
Takeda A; Fujii H; Minamino T; Tamano H
J Neurosci Res; 2014 Jul; 92(7):819-24. PubMed ID: 24723300
[TBL] [Abstract][Full Text] [Related]
10. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
11. Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.
Bjorklund NL; Reese LC; Sadagoparamanujam VM; Ghirardi V; Woltjer RL; Taglialatela G
Mol Neurodegener; 2012 May; 7():23. PubMed ID: 22640423
[TBL] [Abstract][Full Text] [Related]
12. Innervation from the entorhinal cortex to the dentate gyrus and the vulnerability to Zn
Takeda A; Tamano H
J Trace Elem Med Biol; 2016 Dec; 38():19-23. PubMed ID: 27267970
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer's disease pathogenesis focused on intracellular Zn
Takeda A; Tamano H
Nihon Yakurigaku Zasshi; 2021; 156(2):71-75. PubMed ID: 33642533
[TBL] [Abstract][Full Text] [Related]
14. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
[TBL] [Abstract][Full Text] [Related]
15. Significance of the degree of synaptic Zn²⁺ signaling in cognition.
Takeda A; Tamano H
Biometals; 2016 Apr; 29(2):177-85. PubMed ID: 26704989
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Zn
Takeda A; Tamano H; Tempaku M; Sasaki M; Uematsu C; Sato S; Kanazawa H; Datki ZL; Adlard PA; Bush AI
J Neurosci; 2017 Jul; 37(30):7253-7262. PubMed ID: 28652412
[TBL] [Abstract][Full Text] [Related]
17. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.
Corona C; Masciopinto F; Silvestri E; Viscovo AD; Lattanzio R; Sorda RL; Ciavardelli D; Goglia F; Piantelli M; Canzoniero LM; Sensi SL
Cell Death Dis; 2010 Oct; 1(10):e91. PubMed ID: 21368864
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
Belluti F; Rampa A; Gobbi S; Bisi A
Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
